These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 2668307)

  • 1. Metoprolol-controlled release, zero order kinetics.
    Kendall MJ
    J Clin Pharm Ther; 1989 Jun; 14(3):159-79. PubMed ID: 2668307
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Controlled release metoprolol formulations. A review of their pharmacodynamic and pharmacokinetic properties, and therapeutic use in hypertension and ischaemic heart disease.
    Plosker GL; Clissold SP
    Drugs; 1992 Mar; 43(3):382-414. PubMed ID: 1374320
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetic and biopharmaceutic aspects of once daily treatment with metoprolol CR/ZOK: a review article.
    Sandberg A; Abrahamsson B; Regårdh CG; Wieselgren I; Bergstrand R
    J Clin Pharmacol; 1990 Feb; 30(S2):S2-16. PubMed ID: 2179280
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tolerability and well-being with metoprolol in a controlled release (CR/ZOK) formulation: a review article.
    Dimenäs E; Dahlöf C
    J Clin Pharmacol; 1990 Feb; 30(S2):S92-7. PubMed ID: 2179287
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Controlled release metoprolol. Clinical pharmacokinetic and therapeutic implications.
    Kendall MJ; Maxwell SR; Sandberg A; Westergren G
    Clin Pharmacokinet; 1991 Nov; 21(5):319-30. PubMed ID: 1773547
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetic and pharmacodynamic evaluation of metoprolol controlled release (CR/ZOK) 50 mg in young subjects.
    Wieselgren I; Lundborg P; Sandberg A; Olofsson B; Bergstrand R
    J Clin Pharmacol; 1990 Feb; 30(S2):S28-32. PubMed ID: 2312776
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A pharmacokinetic and pharmacodynamic comparison of metoprolol CR/ZOK with a conventional slow release preparation.
    Oosterhuis B; Jonkman J; Zuiderwijk P; Sollie F
    J Clin Pharmacol; 1990 Feb; 30(S2):S33-8. PubMed ID: 2312777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design of a new multiple-unit controlled-release formulation of metoprolol--metoprolol CR.
    Sandberg A; Ragnarsson G; Jonsson UE; Sjögren J
    Eur J Clin Pharmacol; 1988; 33 Suppl():S3-7. PubMed ID: 3371391
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetic and pharmacodynamic properties of controlled release (CR/ZOK) metoprolol in healthy Oriental subjects: a comparison with conventional formulations of metoprolol and atenolol.
    Darmansjah I; Wong E; Setiawati A; Moeloek D; Irawati D; Siagian M; Muchtar A
    J Clin Pharmacol; 1990 Feb; 30(S2):S39-45. PubMed ID: 2312778
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetic and pharmacodynamic comparison of metoprolol CR/ZOK once daily with conventional tablets once daily and in divided doses.
    Lücker P; Moore G; Wieselgren I; Olofsson B; Bergstrand R
    J Clin Pharmacol; 1990 Feb; 30(S2):S17-27. PubMed ID: 2312775
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetic analysis of modified-release metoprolol formulations: An interspecies comparison.
    De Thaye E; Vervaeck A; Marostica E; Remon JP; Van Bocxlaer J; Vervaet C; Vermeulen A
    Eur J Pharm Sci; 2017 Jan; 97():135-142. PubMed ID: 27816630
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Achieving optimal beta1-blockade with metoprolol CR/Zok.
    Wikstrand J
    Basic Res Cardiol; 2000; 95 Suppl 1():I46-51. PubMed ID: 11192353
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The relationship between metoprolol plasma concentration and beta 1-blockade in healthy subjects: a study on conventional metoprolol and metoprolol CR/ZOK formulations.
    Abrahamsson B; Lücker P; Olofsson B; Regårdh CG; Sandberg A; Wieselgren I; Bergstrand R
    J Clin Pharmacol; 1990 Feb; 30(S2):S46-54. PubMed ID: 1968913
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetic and pharmacodynamic properties of a new controlled-release formulation of metoprolol: a comparison with conventional tablets.
    Sandberg A; Blomqvist I; Jonsson UE; Lundborg P
    Eur J Clin Pharmacol; 1988; 33 Suppl():S9-14. PubMed ID: 3371395
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The pharmacokinetics and pharmacodynamics of metoprolol after conventional and controlled-release administration in combination with hydrochlorothiazide in healthy volunteers.
    Lundborg P; Abrahamsson B; Wieselgren I; Walter M
    Eur J Clin Pharmacol; 1993; 45(2):161-3. PubMed ID: 8223839
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of a controlled release (CR/ZOK) formulation of metoprolol, once daily, with conventional metoprolol tablets, twice daily, in mild to moderate hypertension.
    Carruthers G; Shearer R; Taylor W; Moore M
    J Clin Pharmacol; 1990 Feb; 30(S2):S61-5. PubMed ID: 2179282
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bioequivalence, pharmacokinetic and pharmacodynamic response to combined extended release formulations of felodipine and metoprolol in healthy volunteers.
    Aberg J; Abrahamsson B; Grind M; Nyberg G; Olofsson B
    Eur J Clin Pharmacol; 1997; 52(6):471-7. PubMed ID: 9342583
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The efficacy of low dose metoprolol CR/ZOK in mild hypertension and in elderly patients with mild to moderate hypertension.
    Jäättelä A; Baandrup S; Houtzagers J; Westergren G
    J Clin Pharmacol; 1990 Feb; 30(S2):S66-71. PubMed ID: 2179283
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extended-release metoprolol succinate in chronic heart failure.
    Tangeman HJ; Patterson JH
    Ann Pharmacother; 2003 May; 37(5):701-10. PubMed ID: 12708950
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beta-adrenoceptor blockade and CNS-related subjective symptoms: a randomized, double-blind, placebo-controlled comparison of metoprolol CR/ZOK, atenolol and propranolol LA in healthy subjects.
    Dimenäs E; Kerr D; Macdonald I
    J Clin Pharmacol; 1990 Feb; 30(S2):S103-7. PubMed ID: 1968912
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.